Login

Interview with Brian Cox, SurgePays CEO, regarding $SURG.|Kevin Brian Cox. Chairman/CEO, SurgePays Inc ; 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
FBN, a unit of FOX News Media with bureaus in Chicago, discusses Rumble's view that Twitter caused 'the worst, most egregious' implications.
00:10:00
Strategy is to create a tech-forward leader in the building products distribution industry|Brad Jacobs,CEO,Jacobs Private Equity LLC
00:10:00
Thomas Hanly Discusses Singular Health’s Growth and Vision in Interactive Q&A with Investors | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
Strategic Insights into Value Arbitrage Investing: A Discussion with Uri Landesman of Platinum Partners | Uri Landesman - President, Platinum Partners Value Arbitrage Fund LP
00:10:00
Mary Burt-Godwin discusses social media safety tips for kids with Brad Rambur.
00:00:00
Daniel Kenny, CEO, Oncosil Medical Ltd
00:10:00
In-Depth Commentary with CEO Andreas Morfiadakis on KlaraBo's Strategic Vision | Andreas Morfiadakis, CEO, KlaraBo Sverige AB.
00:10:00
The Struggle for Decent Politics: Liberalism and Democracy|Michael Walzer,Professor,Institute for Advanced Studies
00:10:00
The Regulatory Revolution Against Mergers: Insights from Robert Atkinson of ITIF’s Schumpeter Project on Competition Policy | Robert Atkinson - President, Information Technology and Innovation Foundation (ITIF)
00:10:00
Invests in breakthrough scientific startups|Dakin Sloss, General Partner,Prime Movers Lab
00:10:00
Legal Insights: Nick Heath and Henry Hood from Hunters Law
00:10:00
Mastering Emotional Investing: Insights from Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants

© 2017 - Neuhu+